Copyright © 2004 by the European Society of Cardiology.
Editorial
Remise in the treatment of in-stent restenosis
a Department of Cardiology, Heart Lung Centre Utrecht, Utrecht, The Netherlands
b The Interuniversity Cardiology Institute, The Netherlands
* Correspondence to: Dr. Pieter A. Doevendans, Department of Cardiology, Heart Lung Centre Utrecht, Location University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Tel.: +31-30-250-9111; fax: +31-30-254-2155
E-mail address: p.doevendans@azu.nl
| The first 10% of the full text of this article appears below. |
This editorial refers to "Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long term follow-up of a matched-pair comparison with intracoronary ß-radiation therapy"1 by P.W. Radke et al. on page 920
For patients and interventional cardiologists, restenosis has been a major disappointment in the field of percutaneous, transluminal coronary angioplasty (PTCA) and patients with restenosis have suffered both physically as well as emotionally. The early spectacular results of treatment gradually faded away within three months and 612 months since the introduction of the intra-coronary stent. It is difficult to find a cardiologist who does not have patients that have been psychologically affected by one or more restenotic events. For the physician,
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary ß-radiation therapy
- Peter W Radke, Stefan Kobella, Axel Kaiser, Andreas Franke, Daniela Schubert, Eberhard Grube, Peter Hanrath, and Rainer Hoffmann
EHJ 2004 25: 920-925.[Abstract] [FREE Full Text]